Delbridge LM - Search Results

1

Myocardial insulin resistance, metabolic stress and autophagy in diabetes.

Mellor KM, Bell JR, Ritchie RH, Delbridge LM. Mellor KM, et al. Among authors: delbridge lm. Clin Exp Pharmacol Physiol. 2013 Jan;40(1):56-61. doi: 10.1111/j.1440-1681.2012.05738.x. Clin Exp Pharmacol Physiol. 2013. PMID: 22804725

2

Characterization of single heart cell contractility by rapid imaging.

Delbridge LM, Harris PJ, Morgan TO. Delbridge LM, et al. Clin Exp Pharmacol Physiol. 1989 Mar;16(3):179-84. doi: 10.1111/j.1440-1681.1989.tb01542.x. Clin Exp Pharmacol Physiol. 1989. PMID: 2721030

3

Effects of endothelin-1 on the contractility of cardiomyocytes from the spontaneously hypertensive rat.

Delbridge LM, Morgan TO, Harris PJ. Delbridge LM, et al. Clin Exp Pharmacol Physiol. 1995 Oct;22(10):755-62. doi: 10.1111/j.1440-1681.1995.tb01931.x. Clin Exp Pharmacol Physiol. 1995. PMID: 8575113

4

Transitory reduction in angiotensin AT2 receptor expression levels in postinfarct remodelling in rat myocardium.

Lax CJ, Domenighetti AA, Pavia JM, Di Nicolantonio R, Curl CL, Morris MJ, Delbridge LM. Lax CJ, et al. Among authors: delbridge lm. Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. doi: 10.1111/j.1440-1681.2004.04034.x. Clin Exp Pharmacol Physiol. 2004. PMID: 15298543

5

Quantitative phase microscopy: a new tool for investigating the structure and function of unstained live cells.

Curl CL, Bellair CJ, Harris PJ, Allman BE, Roberts A, Nugent KA, Delbridge LM. Curl CL, et al. Among authors: delbridge lm. Clin Exp Pharmacol Physiol. 2004 Dec;31(12):896-901. doi: 10.1111/j.1440-1681.2004.04100.x. Clin Exp Pharmacol Physiol. 2004. PMID: 15659056

6

Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure.

Domenighetti AA, Wang Q, Egger M, Richards SM, Pedrazzini T, Delbridge LM. Domenighetti AA, et al. Among authors: delbridge lm. Hypertension. 2005 Aug;46(2):426-32. doi: 10.1161/01.HYP.0000173069.53699.d9. Epub 2005 Jul 5. Hypertension. 2005. PMID: 15998712

7

Cardiac hypertrophy, substrate utilization and metabolic remodelling: cause or effect?

Ritchie RH, Delbridge LM. Ritchie RH, et al. Among authors: delbridge lm. Clin Exp Pharmacol Physiol. 2006 Jan-Feb;33(1-2):159-66. doi: 10.1111/j.1440-1681.2006.04342.x. Clin Exp Pharmacol Physiol. 2006. PMID: 16445716 Review.

8

The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivo.

Ritchie RH, Quinn JM, Cao AH, Drummond GR, Kaye DM, Favaloro JM, Proietto J, Delbridge LM. Ritchie RH, et al. Among authors: delbridge lm. J Mol Cell Cardiol. 2007 Jun;42(6):1119-28. doi: 10.1016/j.yjmcc.2007.03.900. Epub 2007 Mar 27. J Mol Cell Cardiol. 2007. PMID: 17490678

9

Functional and metabolic remodelling in GLUT4-deficient hearts confers hyper-responsiveness to substrate intervention.

Huggins CE, Domenighetti AA, Ritchie ME, Khalil N, Favaloro JM, Proietto J, Smyth GK, Pepe S, Delbridge LM. Huggins CE, et al. Among authors: delbridge lm. J Mol Cell Cardiol. 2008 Feb;44(2):270-80. doi: 10.1016/j.yjmcc.2007.11.020. Epub 2007 Dec 8. J Mol Cell Cardiol. 2008. PMID: 18191142

10

The intrinsic resistance of female hearts to an ischemic insult is abrogated in primary cardiac hypertrophy.

Bell JR, Porrello ER, Huggins CE, Harrap SB, Delbridge LM. Bell JR, et al. Among authors: delbridge lm. Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1514-22. doi: 10.1152/ajpheart.01283.2007. Epub 2008 Feb 1. Am J Physiol Heart Circ Physiol. 2008. PMID: 18245562 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters